Tarsus Pharmaceuticals to acquire Alkeus for up to $800M
Tweet Send to a Friend
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) announced a definitive agreement to acquire Alkeus Pharmaceuticals, Inc., a privately held biotechnology company developing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




